Hey1, a downstream effector of the Notch pathway, enhances the invasive and migratory capacities of glioblastoma by suppressing the transcription of the deubiquitinase USP11, which is associated with promyelocytic leukaemia (PML) [78,79,80]. This evidence concerns the gene HEY1 and glioblastoma.